Introduction {#sec1}
============

Neurons in the CNS are particularly sensitive to injury and degenerative conditions that frequently result in cell death. Although adult neurogenesis persists in restricted brain areas ([@bib14; @bib21; @bib30; @bib33]), neurons do not regenerate in most regions of the adult CNS. An unmet challenge in neural injury and degeneration repair is how to replenish lost neurons for functional recovery.

Cell fate reprogramming provides new means for regenerating damaged or dead neurons ([@bib3; @bib11; @bib39]). Not only can cells in culture be reprogrammed into pluripotent stem cells ([@bib60]), lineage-restricted stem cells ([@bib28; @bib48]), and different postmitotic cell fates ([@bib17; @bib18; @bib24; @bib34; @bib65]), but they are also amenable to in vivo fate conversion ([@bib15; @bib20; @bib42; @bib45; @bib53; @bib56; @bib57; @bib63; @bib68]). In regards to the CNS, resident glial cells have been directly or indirectly converted into functional neurons in the adult brain and spinal cord ([@bib15; @bib20; @bib42; @bib56; @bib57; @bib63]). Glial cells are broadly distributed and comprise nearly half of the cells in the mammalian CNS. These cells become reactive, proliferate, and form glial scars in response to neural injuries and degeneration ([@bib23; @bib52]). These reactive responses are initially beneficial, restricting the spread of damage, but ultimately are deleterious, acting as both a physical and chemical barrier to neuronal regeneration ([@bib23; @bib52]). Reprogramming some of these glial cells to functional neurons may constitute a novel therapeutic strategy for diseases associated with the CNS.

Through in vivo screens of candidate factors that are able to induce neurogenesis in non-neurogenic regions of the adult brain and spinal cord, we previously showed that the ectopic expression of SOX2 is sufficient to reprogram resident astrocytes to DCX^+^ induced adult neuroblasts (iANBs) ([@bib42; @bib56]). These iANBs pass through a proliferative state and generate mature neurons when supplied with neurotrophic factors. This SOX2-driven in vivo reprogramming process sharply contrasts direct lineage conversion strategies ([@bib15; @bib45; @bib53; @bib57; @bib63; @bib68]), which change cell fate in a linear fashion without amplification of the induced cell population. However, the cellular mechanism underlying SOX2-dependent in vivo reprogramming of astrocytes was unclear. Furthermore, the subtypes of iANB-derived neurons were not well characterized. In this study, we reveal that SOX2-driven reprogramming of astrocytes transits through intermediate neural progenitor states before the adoption of a mature neuron fate. Immunohistochemistry and electrophysiology further show that induced neurons are functionally mature and predominantly express the marker calretinin.

Results {#sec2}
=======

Ectopic Expression of SOX2, but Not the Other SOXB1 Factors, Results in iANBs {#sec2.1}
-----------------------------------------------------------------------------

SOX2 belongs to the SOXB1 subfamily of high-mobility group-box transcription factors, which also includes SOX1 and SOX3 ([@bib50]). These factors are critical for specifying and maintaining the undifferentiated state of neural precursors. The expression of SOXB1 factors during SOX2-mediated in vivo reprogramming were investigated using immunohistochemistry ([@bib42]). The adult mouse striatum was injected with lentivirus expressing SOX2 under the human *GFAP* promoter. When analyzed 4 weeks post-injection (wpi), DCX^+^ iANBs were robustly detected in the virus-injected regions, confirming our previous results ([@bib42]). Interestingly, SOX1 can also be detected in striatal regions with iANBs, especially in DCX^+^ cell clusters ([Figure 1](#fig1){ref-type="fig"}A). However, SOX1 expression is lower in iANBs than neighboring DCX^−^ cells, which is consistent with previous findings that the continued high-level expression of SOXB1 factors prohibits neuronal differentiation ([@bib8; @bib42]). In contrast, SOX3 is only sporadically distributed in the adult striatum and is not detectable in DCX^+^ iANBs ([Figure 1](#fig1){ref-type="fig"}A). Due to sequence and potential functional similarity ([@bib8]), we investigated whether the SOXB1 proteins can similarly induce DCX^+^ cells. Lentiviruses expressing SOX1 or SOX3 under the *GFAP* promoter were individually injected into the adult striatum. However, when examined at 4 or 5 wpi, no DCX^+^ cells were detected in striatal regions with ectopic SOX1 or SOX3 expression, in sharp contrast to areas injected with SOX2-expressing virus that contain DCX^+^ cells ([Figure 1](#fig1){ref-type="fig"}B). Together, these data indicate that SOX2 has a unique property among the SOXB1 factors, enabling the reprogramming of resident astrocytes to iANBs.

SOX2-dependent iANBs in the adult striatum were further examined by injections of lentivirus expressing GFP-T2A-SOX2 under the *GFAP* promoter ([Figure S1](#app2){ref-type="sec"}). The co-expressed stable GFP marked virus-transduced cells. Immunohistochemical analysis showed that about 23.2% ± 5.3% of GFP^+^ cells (mean ± SD; n = 17,841 GFP^+^ cells counted in sections from three mice) stained positive for DCX ([Figure S1](#app2){ref-type="sec"}). This suggests a relatively efficient induction of iANBs from SOX2-expressing cells.

iANBs Are Not the Progeny of Induced Neural Stem Cells {#sec2.2}
------------------------------------------------------

Adult neurogenesis is a multistep process that starts with multipotent neural stem cells (NSCs) that gradually transition into DCX^+^ neuroblasts ([@bib21; @bib25; @bib30; @bib36]). Both SOX1 and SOX2 are expressed in NSCs that can give rise to neurons and glia ([@bib58; @bib64]). The residual expression of these factors in DCX^+^ iANBs suggests that ectopic SOX2 might reprogram astrocytes into a multipotent NSC state. We surveyed the expression of several additional markers for NSCs surrounding striatal regions injected with SOX2-expressing virus at 4 wpi. Nestin (NES), an intermediate filament protein highly enriched in embryonic and adult NSCs ([@bib32]), can be sparsely detected in neighboring regions with iANBs ([Figure S2](#app2){ref-type="sec"}). Similarly, cells expressing brain-lipid-binding protein, a marker for radial glia in developing brain and type-1 and type-2 neural precursors of the adult dentate gyrus (DG) ([@bib13; @bib55]), are intermingled with iANBs in the adult striatum. GFAP^+^ cells are also found in the vicinity of iANBs ([Figure S2](#app2){ref-type="sec"}). GFAP is robustly induced in reactive astrocytes and also labels NSCs in the adult lateral ventricle (LV) and DG ([@bib12; @bib30; @bib33]). Although the above markers were not detected in DCX^+^ cells, these data support a hypothesis that iANBs might be derived from SOX2-induced NSCs in the striatum.

We directly examined this hypothesis using a lineage-tracing strategy. When adult *Nes-CreER*^*TM*^;*Rosa-YFP* mice were treated with tamoxifen for 7 days and examined 3 weeks later, DCX^+^ cells in the LV and DG were robustly labeled with the YFP reporter ([Figures 2](#fig2){ref-type="fig"}A and 2B). This result confirms that neuroblasts from endogenous NSCs can be specifically traced in this transgenic mouse line ([@bib31; @bib42]). We then injected SOX2-expressing lentivirus into the striatum of adult *Nes-CreER*^*TM*^;*Rosa-YFP* mice, administered tamoxifen at 2 or 3 wpi, and performed immunohistochemistry after another 3 weeks. As internal controls, endogenous neuroblasts in the LV were traced with the marker YFP. In sharp contrast, none of the SOX2-induced DCX^+^ cells in the striatum were YFP labeled, indicating that ectopic SOX2 does not reprogram astrocytes into a NSC-like state ([Figures 2](#fig2){ref-type="fig"}C and 2D).

SOX2 Induces ASCL1^+^ Neural Progenitors {#sec2.3}
----------------------------------------

ASCL1^+^ neural progenitors precede the development of DCX^+^ neuroblasts during adult neurogenesis ([@bib28; @bib35]). Very interestingly, ASCL1^+^ cells can be specifically detected in the striatal regions around DCX^+^ iANBs when injected with SOX2, but not a control virus, at 5 wpi ([Figure 3](#fig3){ref-type="fig"}A). A time course analysis further showed that the number of ASCL^+^ cells gradually increases post-injection of SOX2 virus, reaches a peak level around 5 wpi, and persists beyond 14 wpi ([Figure 3](#fig3){ref-type="fig"}B). We used the *GFAP*-GFP marker to label virus-transduced astrocytes in the adult striatum and revealed specific ASCL1 expression in these GFP^+^ cells, which clustered with SOX2-induced DCX^+^ cells ([Figure 3](#fig3){ref-type="fig"}C).

The above results suggest that ASCL1^+^ cells might be the precursors of iANBs during SOX2-driven in vivo astrocyte reprogramming. We examined this possibility using *Ascl1-CreER*^*T2*^ mice, in which the tamoxifen-inducible *CreER*^*T2*^ was knocked into the endogenous *Ascl1* locus ([@bib29]). After crossing to mice harboring the Cre-activity-dependent *Rosa-tdTomato* (*tdT*) reporter ([@bib38]), ASCL1^+^ cells and their progeny can be uniquely traced. These adult mice were injected with a SOX2-expressing or control virus, administered tamoxifen for 7 days starting at 2 wpi, and examined at 6 wpi ([Figure 3](#fig3){ref-type="fig"}D). Whereas no tdT^+^ cells were detected in striatal regions injected with the control virus, these cells were robustly distributed in regions injected with the SOX2 virus ([Figure 3](#fig3){ref-type="fig"}E). Consistent with the hypothesis that iANBs are derived from ASCL1^+^ neural progenitors, over 90% of SOX2-induced DCX^+^ cells could be labeled by tdT. Together, these data show that ectopic SOX2 reprograms striatal astrocytes to ASCL1^+^ neural progenitors, which subsequently give rise to DCX^+^ iANBs.

ASCL1 Is Required, but Not Sufficient, for Generation of iANBs {#sec2.4}
--------------------------------------------------------------

ASCL1 is a neural specific basic helix-loop-helix transcription factor and essential for neurogenesis during early nervous system development ([@bib9; @bib40; @bib62]). The induction of ASCL1 in the adult striatum suggests that it may be critical for SOX2-driven in vivo reprogramming of astrocytes. To examine this possibility, we used genetically modified mice that contain conditional alleles of *Ascl1* (*Ascl1*^*f/f*^; [@bib44]) and a tamoxifen-inducible *CreER*^*T2*^ transgene under the astrocyte-specific *Cst3* promoter ([Figure 4](#fig4){ref-type="fig"}A) ([@bib42]). These adult mice were treated with tamoxifen or vehicle for 7 days and then injected with SOX2-expressing lentivirus. Immunohistochemistry was performed 5 wpi and revealed a dramatic reduction in the population of DCX^+^ iANBs upon inducible deletion of *Ascl1* ([Figures 4](#fig4){ref-type="fig"}B and 4C). The few residual DCX^+^ cells might be due to an incomplete deletion of *Ascl1* in all the SOX2 virus-infected astrocytes. These data indicate that ASCL1 plays a critical role in SOX2-driven reprogramming.

Ectopic ASCL1 is sufficient to promote the neuronal differentiation of embryonic stem cells and NSCs ([@bib6; @bib10]), as well as reprogram cultured fibroblasts and early postnatal astroglia to neurons ([@bib10; @bib18]), demonstrating a dominant role for ASCL1 in cell fate specification. To investigate whether ASCL1 itself is also able to induce DCX^+^ neuroblasts in the adult striatum, we injected lentivirus expressing ASCL1 under the *GFAP* promoter and analyzed 1, 2, 3, and 5 wpi ([Figure 4](#fig4){ref-type="fig"}D). Unexpectedly, DCX^+^ cells were not observed in regions with robust expression of exogenous ASCL1 ([Figure 4](#fig4){ref-type="fig"}E). These results suggest that ASCL1 has important roles in the SOX2-driven reprogramming process but is not itself sufficient to induce cell fate switch in the adult striatum.

iANBs Mostly Generate Calretinin^+^ Interneurons {#sec2.5}
------------------------------------------------

We previously showed that iANBs can give rise to functionally mature neurons upon treatment with brain-derived neurotrophic factor (BDNF) and noggin or with the small molecule valproic acid (VPA) ([@bib42]). However, the subtype of neurons generated by these treatments was unclear. We surveyed the expression of markers for striatal neurons by immunohistochemistry in regions injected with SOX2 virus at 8 wpi. To promote neuron survival and maturation, some of these mice were also injected with virus expressing BDNF or BDNF-noggin or were treated with VPA for 4 weeks starting at 4 wpi ([Figures S3](#app2){ref-type="sec"}A and S3B). Among all these treatment groups, we did not notice any major change in the populations of neurons expressing parvalbumin, somatostatin, choline acetyltransferase, tyrosine hydroxylase, or DARPP32 ([Figure S3](#app2){ref-type="sec"}C; data not shown). In sharp contrast, we observed a dramatic induction of calretinin neurons in striatal regions of mice injected with SOX2 virus and treated with the neurotrophic factors or small molecule ([Figures S3](#app2){ref-type="sec"}C and S3D). This combination treatment was essential for the induction of calretinin neurons, as they were not observed in mice injected with only virus or treated with only VPA.

We performed bromodeoxyuridine (BrdU) tracing to confirm these calretinin neurons were indeed newly induced. Adult mice were injected singularly or in combination with viruses expressing SOX2, BDNF, noggin, or BDNF-noggin. A cohort of SOX2 virus-injected mice was also treated with VPA in drinking water for 4 weeks beginning at 4 wpi. All mice were administered BrdU for 4 weeks to label newly generated cells ([Figure 5](#fig5){ref-type="fig"}A). When analyzed at 8 wpi, 30%--70% of calretinin cells could be traced by BrdU in striatal regions injected with SOX2 virus and treated with either neurotropic factors or VPA ([Figure 5](#fig5){ref-type="fig"}B). A majority of these BrdU^+^ calretinin^+^ neurons were also NEUN^+^, a marker for mature neurons ([Figure 5](#fig5){ref-type="fig"}C). These neurons were not detectable in any of the control groups, confirming that the long-term survival and maturation of SOX2-induced neurons requires neurotrophic factors ([@bib42]).

Cell-of-origin tracing was used to map the lineage of induced calretinin^+^ neurons in transgenic mice. Astrocytes were specifically labeled by tamoxifen-inducible expression of YFP in adult *Cst3-CreER*^*T2*^;*Rosa-YFP* mice ([Figure 5](#fig5){ref-type="fig"}D) ([@bib42]). Three weeks later, these mice received striatal injections of SOX2-expressing lentivirus and were treated with VPA for 4 weeks starting at 5 wpi. When analyzed at 10 wpi, calretinin^+^ neurons were uniquely traced by YFP, indicating an origin from adult striatal astrocytes ([Figure 5](#fig5){ref-type="fig"}E). However, not all calretinin^+^ neurons were YFP^+^, a result that might be due to the incomplete labeling of striatal astrocytes by the inducible approach and a few preexisting endogenous calretinin^+^ neurons.

*Ascl1-CreER*^*T2*^;*Rosa-tdT* mice were employed to further examine whether SOX2-induced calretinin^+^ neurons pass through an ASCL1^+^ intermediate progenitor stage ([Figure 5](#fig5){ref-type="fig"}F). These adult mice were first injected with SOX2-expressing lentivirus to induce reprogramming and treated with tamoxifen at 2 wpi to label cells derived from ASCL1^+^ progenitors. When examined at 6 wpi, many of the calretinin^+^ interneurons were tdT^+^ ([Figure 5](#fig5){ref-type="fig"}G), indicating that they were indeed derived from SOX2-induced ASCL1^+^ progenitors. As controls, calretinin^+^ tdT^+^ cells were not detectable in striatal regions injected with GFP-expressing lentivirus. The long-term survival of SOX2-induced neurons was determined at 36 wpi ([Figure S3](#app2){ref-type="sec"}E). About 94.6% ± 0.9% tdT^+^ cells (mean ± SD; n = 369 tdT^+^ cells from three mice) were NeuN^+^, indicating that a majority of the induced neurons become mature and exhibit long-term survival in the endogenous environment ([Figure S3](#app2){ref-type="sec"}F).

Functional Heterogeneity of Induced Neurons {#sec2.6}
-------------------------------------------

We conducted whole-cell patch clamp recordings on reprogrammed striatal neurons using live brain slices from adult *Ascl1-CreER*^*T2*^;*Rosa-tdT* mice. Mice at 2--4 months of age were injected with SOX2-expressing lentivirus to initiate the reprogramming of astrocytes and 2 weeks later treated with tamoxifen for 7 days to trace induced neurons. To promote the survival and maturation of induced neurons, mice were also treated with VPA for at least 4 weeks starting at 4 wpi. Electrophysiology was performed from 8 to 40 wpi. The morphology of recorded cells was visualized by the infusion of biocytin through recording pipettes ([Figure 6](#fig6){ref-type="fig"}A).

Based on resting membrane potential and input resistance, the induced neurons can be broadly grouped into four subtypes ([Figures 6](#fig6){ref-type="fig"}B--6D). The vast majority of the induced neurons (type I; n = 20/27) exhibit hyperpolarized resting membrane potential at −80 mV and have a lower input resistance (30--80 MΩ). Type II neurons (n = 2/27) are similarly hyperpolarized around −80 mV but show a much-higher input resistance (200--1,000 MΩ). The resting membrane potential of type III (n = 2/27) and type IV (n = 3/27) neurons is −60 mV; however, the respective input resistances differ widely, ∼150 MΩ and ∼2,000 MΩ. Cell capacitance, which usually serves as an indicator of cell size and channel abundance on the membrane, varies broadly among these recorded neurons ([Figure 6](#fig6){ref-type="fig"}E).

Functional maturity was examined by the ability to fire action potentials (APs), which were elicited by a series of current-step injections. All induced neurons fired repetitive APs when depolarized beyond the AP threshold (n = 27/27; [Figures 6](#fig6){ref-type="fig"}F and [S4](#app2){ref-type="sec"}A). Although the AP threshold ([Figure 6](#fig6){ref-type="fig"}G) and delay of the first AP spike ([Figure S4](#app2){ref-type="sec"}B) were within a broad range, type I neurons exhibited larger amplitudes and higher firing frequencies (n = 20; [Figures 6](#fig6){ref-type="fig"}H and 6I). On the other hand, type IV induced neurons had a wider AP half-width ([Figure 6](#fig6){ref-type="fig"}J) and slower velocity of AP rise and decay (n = 3; [Figures S4](#app2){ref-type="sec"}C and S4D). Interestingly, type III induced neurons spontaneously fired APs at their resting membrane potential ([Figures S3](#app2){ref-type="sec"}E and [S4](#app2){ref-type="sec"}F), a phenomenon widely observed in many CNS neurons. These neurons might function in the synchronization of circuit activity or sustain modulatory inputs onto postsynaptic neurons ([@bib16; @bib37]).

By depolarizing the induced neurons from −60 mV to +60 mV in 10-mV increments, we further examined the behaviors of sodium and potassium channels ([Figure S4](#app2){ref-type="sec"}G). The large inward current from voltage-gated sodium channels was completely blocked by the application of tetrodotoxin ([Figure S4](#app2){ref-type="sec"}H). These sodium currents (*I*~*Na*~) varied broadly and were not considerably different between subtypes of induced neurons ([Figure S4](#app2){ref-type="sec"}I). The outward currents in the plateau phase of the voltage step represent delayed rectifier potassium currents (*I*~*d*~; [Figure S4](#app2){ref-type="sec"}G), which were much lower in type IV induced neurons ([Figure S4](#app2){ref-type="sec"}J). The approximate summation of fast potassium current (*I*~*A*~) and *I*~*d*~ collectively represent the outward current immediately following the inward sodium current. *I*~*A*~ was smaller in type IV induced neurons than the other three types ([Figure S4](#app2){ref-type="sec"}K). These data suggest that ion channel distributions in type IV induced neurons are different from the other three types.

Neuron connectivity within the local circuitry was investigated by recording spontaneous postsynaptic currents (sPSCs). All of the analyzed neurons showed robust sPSCs with comparable average amplitudes, although the frequency was lower in type IV induced neurons ([Figures 6](#fig6){ref-type="fig"}K--6M). These results indicate that all of the induced neurons have efficiently integrated into the local neuronal networks and received inputs from presynaptic neurons.

Discussion {#sec3}
==========

This study used genetic fate mapping to reveal that SOX2-driven in vivo reprogramming of adult astrocytes passes through a sequence of distinct cell states ([Figure 7](#fig7){ref-type="fig"}), which mimics aspects of endogenous neurogenesis. Ectopic SOX2 converts astrocytes to ASCL1^+^ intermediate progenitors, which proliferate and generate DCX^+^ neuroblasts. These early neuroblasts can expand and eventually generate mature neurons when supplied with neurotrophic factors. Expansion through the intermediate progenitors and neuroblasts enable one reprogrammed astrocyte to make multiple functional neurons, which might be therapeutically beneficial for regenerative medicine in treating neural injuries or degeneration.

Although previous work showed that SOX2 is sufficient to convert fibroblasts into NES^+^ multipotent NSCs under a unique culture condition ([@bib48]), our genetic approach using *Nes-CreER*^*T2*^;*Rosa-YFP* mice failed to detect a stable NSC state during the in vivo reprogramming process. This difference highlights the critical importance of the microenvironment in cell fate reprogramming and suggests that additional factors are required to enable SOX2 to convert glial cells into multipotent stem cells in the adult CNS. Our initial in vivo screens for reprogramming factors included the four factors for induced pluripotent stem cells ([@bib42]); however, this combination of factors has been subsequently shown to induce tumorigenesis in vivo ([@bib1; @bib43]) and raised serious concerns about the therapeutic value of in vivo induced pluripotent stem cells. In contrast, we have not observed any histological signs of tumorigenesis in brains or spinal cords with ectopic SOX2 expression when examined up to 1 year post virus injection. This is consistent with a recent study showing that multiple key transcription factors are required to initiate brain tumors in vivo ([@bib59]).

Adult neurogenesis is a multistep process beginning with multipotent NSCs that yield transient amplifying neural progenitors and then mature neurons ([@bib14; @bib21; @bib30; @bib33]). Our immunohistochemistry and genetic fate-mapping experiments demonstrate that SOX2-driven in vivo reprogramming passes through an ASCL1^+^ intermediate progenitor stage. These progenitors give rise to DCX^+^ neuroblasts, which can further proliferate and expand the neuronal lineage ([@bib42]). This sequential and multistage amplification process is consistent with what has been observed in the adult neurogenic niches, suggesting that the reprogrammed glial cells have adopted the behavior of endogenous progenitors ([@bib29; @bib35]). ASCL1 serves as a molecular marker of neural progenitors and also controls their activity, including proliferation and differentiation ([@bib2; @bib4; @bib22; @bib26; @bib27]). Consistently, our conditional deletion of *Ascl1* in astrocytes shows that it is critically important for robust in vivo reprogramming. Nonetheless, ASCL1 cannot replace SOX2 in the induction of neurogenesis from adult astrocytes, as DCX^+^ iANBs are rarely detected in striatal regions with ectopic ASCL1 during a series of time course analyses. This result agrees with a recent in vivo study ([@bib20]) and suggests that additional factors are also required in combination with ASCL1 to mediate SOX2 function in cell fate reprograming in the adult brain. In contrast, ASCL1 alone is able to transdifferentiate early postnatal astroglia ([@bib17; @bib19]), fibroblasts ([@bib10]), and embryonic stem cells ([@bib10]) into functional neurons in culture. This discrepancy between results from in vitro and in vivo studies once again highlights the importance of the cellular milieu in cell fate specification, determination, and reprogramming.

A survey of markers for neuronal subtypes reveals that a larger population of SOX2-induced neurons expresses calretinin, a calcium-binding protein in GABAergic interneurons ([@bib61]). Interestingly, calretinin was shown to be transiently co-expressed with DCX during the early stage of adult hippocampal neurogenesis and subsequently downregulated once newly born neurons become mature 6 weeks later ([@bib7]). In contrast, calretinin is rarely detectable in iANBs but continuously expressed once they develop into mature neurons by 8 wpi, suggesting the stable generation of this neuronal subtype. The preferential reprogramming of striatal astrocytes by SOX2 to calretinin^+^ neurons was unexpected but is most likely due to signaling cues present in the adult striatum or intrinsic factors residing in the striatal astrocytes. It will be interesting in the future to tease out these instructive factors for the generation of specific neuron subtypes.

Endogenous calretinin^+^ interneurons make up 0.5% of striatal neurons in the rodent but are more prevalent in humans ([@bib49; @bib67]). These neurons are diverse in morphology with limited electrophysiological characterization ([@bib61]). Electrophysiological analyses show that the induced neurons are heterogeneous, although the majority is hyperpolarized with lower input resistance and higher AP amplitude and frequency. This heterogeneity may reflect functional diversity and/or the progressive nature of neuronal maturation and integration into the local circuits. Interestingly, a minority of the recorded neurons exhibit pacemaker-like activity and fire spontaneous APs at resting membrane potential. This activity is prevalent in striatal cholinergic neurons, subthalamic nucleus neurons, midbrain dopaminergic neurons, cerebellar Purkinje and Golgi neurons, and low-threshold spike interneurons of the striatum ([@bib5; @bib47; @bib51]). The pace-making activity of these neurons can synchronize neuronal networks for higher-order brain functions ([@bib46]).

The ability to reprogram glial cells into functional neurons in the adult CNS has reshaped our knowledge of cell fate maintenance and brought a new perspective to cell-based regenerative medicine for neurological diseases. The results of this study provide new insights into the cellular processes of SOX2-driven in vivo reprogramming, which may be useful for future strategies aimed at improving reprogramming efficiency and the derivation of disease-relevant neuron subtypes.

Experimental Procedures {#sec4}
=======================

Animals {#sec4.1}
-------

The following mutant mouse lines were used in this study: *Cst3-CreER*^*T2*^ ([@bib42]), *Nes-CreER*^*TM*^ ([@bib31]), *Ascl1-CreER*^*T2*^ ([@bib29]), *Ascl1*^*neoflox/neoflox*^ (floxed allele of *Ascl1* mutant mice with the *neo* cassette, here referred to as *Ascl1*^*f/f*^; [@bib44]), *Rosa-YFP* ([@bib54]), and *Rosa-tdTomato* (Ai14; *Rosa-tdT*; [@bib38]). Adult male and female mice at 2--6 months of age were used unless otherwise stated. All mice were housed under a 12 hr light/dark cycle and had ad libitum access to food and water in a controlled animal facility. Experimental protocols were approved by the Institutional Animal Care and Use Committee at UT Southwestern.

Tamoxifen, VPA, and BrdU Administration {#sec4.2}
---------------------------------------

Tamoxifen (T5648; Sigma) was dissolved in a mixture of ethanol and sesame oil (10:90 by volume) at a concentration of 40 mg/ml and stored at 4°C. It was intraperitoneally injected at a daily dose of 4 mg/40 g body weight daily for 5--7 days. VPA (P4543; Sigma) in drinking water (4 g/l) was administered for 4 weeks. BrdU (B5002; Sigma; 10 mg/kg body weight in PBS) was applied by daily intraperitoneal injection for 4 weeks.

Virus Preparation and Intracerebral Injections {#sec4.3}
----------------------------------------------

The lentiviral vectors *GFAP-GFP*, *GFAP-SOX2*, *GFAP-GFP-T2A-SOX2*, *GFAP-GFP-T2A-Bdnf*, and *GFAP-GFP-T2A-Noggin* were generated as previously described ([@bib42]). A final volume of 2 μl virus with an original titer of 0.5--1 × 10^9^ colony-forming units per ml was stereotactically injected into the striatum of adult mice with a coordinate of anterior/posterior, +1.0 mm; medial/lateral, ±2 mm; and dorsal/ventral from skull, −3.0 mm.

Immunohistochemistry {#sec4.4}
--------------------

Adult mice were euthanized with CO~2~ overdose and sequentially perfused with ice-cold PBS and 4% paraformaldehyde (PFA) in PBS. Brains were collected and postfixed with 4% PFA for 4--6 hr or overnight at 4°C. Postfixed brains were cryoprotected with 30% sucrose solution in PBS for 24 hr and cut into 40-μm-thick sections with a sliding microtome (Leica). Brain sections were serially collected and stored in antifreezing solution at −20°C. Immunohistochemistry was performed essentially as previously described ([@bib41]). Briefly, free-floating sections were rinsed with PBS and blocked with blocking solution (3% BSA and 0.2% Triton X-100 in PBS) for 1 hr at room temperature. These sections were incubated with primary antibodies diluted in blocking solution for at least 24 hr at 4°C followed by three rinses with PBST buffer (0.2% Triton X-100 in PBS). They were subsequently incubated with respective secondary antibodies diluted in blocking solution for over 2 hr at room temperature. Nuclei were counterstained with Hoechst 33342 when appropriate. After extensive rinsing with PBST buffer, sections were mounted onto glass slides for microscopy. The following primary antibodies were used: GFP (A-11122, rabbit, 1:500, Invitrogen; GFP, chick, 1:1,000, Aves Labs), GFAP (G3893; mouse; 1:500; Sigma), BrdU (OBT0030; rat BU1/75; 1:500; Accurate Chemical), NEUN (MAB377; mouse; 1:500; Millipore), SOX1 (4194S; rabbit; 1:500; Cell Signaling Technology), SOX2 (AB5603; rabbit; 1:500; Millipore), SOX3 (rabbit; 1:200; a gift from M. Klymkowsky; [@bib66]), BLBP (AB9558; rabbit; 1:500; Millipore), NES (556309; mouse; 1:200; BD PharMingen), KI-67 (NCL-Ki67; rabbit; 1:500; Novocastra), DCX (sc-8066; goat; 1:150; Santa Cruz Biotechnology), OLIG2 (AB9610; rabbit; 1:500; Millipore), glutamine synthetase (MAB302; mouse; 1:500; Chemicon), PSA-NCAM (5A5-a; mouse; 1:250; Hybridoma bank), NG2 (MAB5384; mouse; 1:500; Millipore), IBA1 (019-19741; rabbit; 1:1,000; Waco), Parvalbumin (P3088; mouse; 1:1,000; Sigma), somatostatin (AB5494; rabbit; 1:500; Chemicon), CHAT (CAT; chick; 1:1,000; Aves), Calretinin (AB702; rabbit; 1:200; Novus), DARPP32 (2302; rabbit; 1:500; Cell Signaling Technology), CC-1 (OP80; mouse; 1:500; Calbiochem), and ASCL1 (TX-518; guinea pig; 1:10,000; Jane Johnson). Alexa-488-, Alexa-Fluor-594-, or Alexa-Fluor-647-conjugated corresponding secondary antibodies from Jackson ImmunoResearch were used for indirect fluorescence. Images were taken using a Zeiss LSM510 confocal microscope. A Cell Counter software plugin in the ImageJ program was used to count cells. Data were obtained from 12 random sections from three to five mice in each group.

Electrophysiology {#sec4.5}
-----------------

Adult mice were deeply anesthetized and transcardially perfused with chilled (4°C) artificial cerebrospinal fluid (ACSF) (119 mM NaCl, 2.5 mM KCl, 26 mM NaHCO~3~, 1 mM NaH~2~PO~4~, 11 mM D-glucose at pH 7.4, 300 mOsm, and aerated with 95% O~2~/5% CO~2~), including 0.5 mM CaCl~2~, 5 mM MgCl~2~, and 1% kynurenate acid. The striatum with overlying neocortex was then dissected out. Acute sagittal slices (250 μm thickness) were collected between +2 mm and −2 mm from bregma on a Leica VT1200S slicer. They were then incubated in aerated ACSF with 3 mM CaCl~2~ and 2 mM MgCl~2~ to recover for 30 min at 35°C followed by additional incubation for over 1 hr at room temperature. A single slice was then transferred to a submersion chamber and perfused at 3 ml/min with aerated ACSF at 30°C. Lineage-traced cells in the striatum were identified under visual guidance using IR-DIC optics and tdTomato fluorescence. Whole-cell current-clamp and voltage-clamp recordings were performed using glass pipettes (∼6--9 MΩ) filled with intracellular solution (0.2 mM EGTA, 130 mM K-gluconate, 6 mM KCl, 3 mM NaCl, 10 mM HEPES, 4 mM ATP-Mg, 0.4 mM GTP-Na, and 14 mM phosphocreatine-Tris at pH 7.2 and 285 mOsm). Intracellular solution was supplemented with 0.5% biocytin (B4261; Sigma) for biocytin labeling. All recordings were obtained with a MultiClamp 700B amplifier. Currents were filtered at 2 kHz, acquired, and digitized at 10 kHz using Clampex10.3 (Molecular Devices). APs were recorded in current clamp mode and elicited by a series of current injections starting from −160 pA with 20-, 40-, 80-, or 160-pA increments and 800 ms duration. Sodium and potassium currents were recorded in voltage-clamp mode in response to a series of voltage steps ranging from −60 mV to +60 mV at 10-mV increments and 100 ms duration. Delayed rectifier potassium currents (*K*~*d*~) were measured 50 ms prior to the end of current step. Spontaneous synaptic currents were recorded in voltage-clamp mode. In all voltage-clamp recordings, cells were clamped at −60 mV or −80 mV, whichever is close to the resting membrane potential of the cell except during the voltage-step protocol. In all current-clamp recordings, recordings were made at the resting membrane potential or without any current injection. Series and input resistance were measured in voltage-clamp mode with a 400 ms, −10 mV step from a −60 mV holding potential (filtered by 10 kHz, sampled at 50 kHz). Cells were accepted only if the series resistance was less than 30 MΩ and stable throughout the experiment. Data analysis was performed in Clampfit10.3 (Molecular Devices).
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![Expression and Reprogramming Ability of SOXB1 Factors\
(A) Immunohistochemistry (IHC) showing expression of SOXB1 factors in striatal regions with iANBs at 5 weeks post-injection (wpi) of SOX2 virus. SOX1 and SOX2, but not SOX3, can be identified in some of the induced DCX^+^ cells (right panels at higher magnifications). Hst, Hoechst 33342. The scale bars represent 20 μm.\
(B) Ectopic SOX2, but not the other SOXB1 factors, induce striatal DCX^+^ cells. Lentivirus expressing individual SOXB1 factors was injected into the adult mouse striatum and examined 4 or 5 weeks (wk) later. The scale bars represent 20 μm.\
See also [Figure S1](#app2){ref-type="sec"}.](gr1){#fig1}

![SOX2-Driven Reprogramming Does Not Pass through a NSC Stage\
(A) A genetic approach to trace NSCs and their progeny. Adult *Nes-CreER*^*TM*^;*Rosa-YFP* mice were injected with tamoxifen (Tam) for 7 days and examined 3 wk later.\
(B) Endogenous NSCs and DCX^+^ cells in the lateral ventricle (LV) and dentate gyrus (DG) are genetically traced. The scale bars represent 20 μm.\
(C and D) iANBs do not pass through a nestin^+^ NSC stage. Adult mutant mice were treated with Tam 2 (C) or 3 (D) wpi of SOX2-expressing virus and examined at the indicated time points. DCX^+^ cells in the LV were used as endogenous controls. The scale bars represent 20 μm.\
See also [Figure S2](#app2){ref-type="sec"}.](gr2){#fig2}

![SOX2 Induces ASCL1^+^ Neural Progenitors\
(A) The expression of ASCL1^+^ cells in striatal regions with DCX^+^ iANBs at 5 wpi. The scale bar represents 20 μm.\
(B) A time course analysis of ASCL1^+^ cells in the reprogramming area (mean ± SD; n = 3 mice at each time point).\
(C) ASCL1 is detected in astrocytes transduced with SOX2 lentivirus. The co-expressed GFP marker is under the control of the human GFAP promoter. The scale bar represents 20 μm.\
(D) A genetic approach to trace derivatives of ASCL1^+^ progenitors. SOX2-driven reprogramming was induced in adult *Ascl1-CreER*^*T2*^;*Rosa-tdTomato* (tdT) mice.\
(E) SOX2-induced DCX^+^ cells pass through an ASCL1^+^ progenitor stage. Confocal images show genetic labeling of iANBs. An orthogonal view is shown in the right panel. The scale bar represents 20 μm.](gr3){#fig3}

![ASCL1 Is Required, but Not Sufficient, for SOX2-Driven Reprogramming\
(A and B) Schematic diagrams show experimental designs. *Ascl1* is deleted in the adult astrocytes after Tam treatment of *Ascl1*^*f/f*^;*Cst3-CreER*^*T2*^ mice. Four weeks later, in vivo reprogramming was initiated by injection of SOX2-expressing lentivirus and examined at 5 wpi.\
(C) Deletion of *Ascl1* dramatically reduces the induction of DCX^+^ cells (mean ± SD; n = 6 for vehicle-treated and n = 4 for Tam-treated mice; ^∗∗^p = 0.0013 by Student's t test).\
(D) The experimental design for examining ASCL1 reprogramming ability.\
(E) DCX^+^ cells were not detected in striatal regions with ectopic ASCL1 when examined at 1, 2, 3, or 5 weeks post virus injection. SOX2-induced DCX^+^ cells were used as positive controls. The scale bar represents 20 μm.](gr4){#fig4}

![Reprogramming of Resident Astrocytes to Calretinin^+^ Neurons\
(A) Experimental schemes. Newly generated cells were labeled by BrdU incorporation. Neuronal survival and maturation were promoted by valproic acid (VPA) or neurotrophic factors.\
(B) Quantification of newly generated calretinin (CR)^+^ neurons under the indicated conditions (mean ± SD; n = 3 mice at each condition). BDNF, brain-derived neurotrophic factor; Nog, noggin.\
(C) Confocal images showing BrdU-labeled CR^+^ neurons that were induced by SOX2. An orthogonal view of the boxed region is also shown. The scale bar represents 20 μm.\
(D and E) SOX2-induced CR^+^ neurons originate from resident astrocytes. Adult resident astrocytes were genetically traced in *Cst3-CreER*^*T2*^;*Rosa-YFP* mice after Tam treatment. These cells were then in vivo reprogrammed by ectopic SOX2 and analyzed 10 weeks later. Soma and processes of the astrocyte-converted CR^+^ neurons are indicated by arrows and arrowheads, respectively. The scale bar represents 20 μm.\
(F and G) SOX2-induced CR^+^ neurons pass through an ASCL1 progenitor stage. The descendants of ASCL1^+^ progenitors were genetically traced in *Ascl1-CreER*^*T2*^;*Rosa-tdT* mice. A majority of the reprogrammed CR^+^ neurons were traced by the marker tdT. The scale bar represents 20 μm.\
See also [Figure S3](#app2){ref-type="sec"}.](gr5){#fig5}

![Functional Properties of SOX2-Induced Neurons\
(A) Representative confocal images of the four types of induced neurons traced in the striatum of adult *Ascl1-CreER*^*T2*^;*Rosa-tdT* mice and infused with biocytin. The scale bars represent 10 μm.\
(B--D) Characterization of the four types of induced neurons based on input resistance (R~in~) and resting membrane potentials (V~0~).\
(E) A majority of the recorded neurons have a capacitance around 30 pF.\
(F) Representative action potential traces from each type of reprogrammed neurons.\
(G) All the induced neurons have a similar action potential (AP) threshold.\
(H and I) A majority of the induced neurons have higher AP amplitudes and frequencies.\
(J) Type IV induced neurons have wider AP half-width.\
(K--M) Properties of spontaneous postsynaptic currents (sPSCs). Whereas there is a broader range of sPSC frequencies, their amplitude is rather similar (n.a., not available).\
For all panels, n = 20 cells from 11 mice for type I neurons, n = 2 cells from two mice for type II neurons, n = 2 cells from one mouse for type III neurons, and n = 3 cells from three mice for type IV neurons.\
See also [Figure S4](#app2){ref-type="sec"}.](gr6){#fig6}

![Stepwise Reprogramming of Resident Astrocytes to Functional Neurons in the Adult Brain](gr7){#fig7}
